Anzeige
Mehr »
Mittwoch, 18.06.2025 - Börsentäglich über 12.000 News
Entsteht hier die interessanteste spekulative Chance im kommenden Rohstoff-Boom?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von FiercePharma

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
20:10Pharma makes Cannes Lions comeback with 'brilliant basics'
18:10Bavarian Nordic sells FDA priority review voucher from chikungunya vaccine approval for $160M
18:10Trump administration considers measures to limit DTC drug advertising: Bloomberg
17:10BioNTech to wind down cell therapy manufacturing in Maryland, lay off 63 as it ends development of CAR-T drug in testicular cancer
DiLawmakers refresh tax-dodging accusations against Big Pharma, targeting Pfizer, AbbVie and others
DiOusted ACIP members fire back at RFK Jr.'s 'destabilizing' decisions for US vaccine policy
DiIPG Health outfits dominate another Cannes agency showdown, with Real Chemistry and Ogilvy Health earning accolades, too
DiPharma roars onto the Cannes Pharma Lions podium, with Viatris winning Grand Prix and Biogen taking home Gold
DiWith FDA nod for HAE drug Andembry, CSL set to compete with Takeda's Takhzyro
DiIn setback for biopharma, Senate version of Trump's tax bill drops Orphan Cures Act
DiTrump rekindles pharmaceutical tariff threat, suggesting import duties could come 'very soon': Reuters
DiShrinking budgets and rising targets pile pressure on pharma marketers: survey
DiSenators bring back bill to bolster US pharma supply chain by awarding contracts to domestic producers
MoRoche, AbbVie say trial of Venclexta in patients with myelodysplastic syndromes falls short
MoVeranova, Enzene plot new biologic manufacturing expansions on East Coast
MoPrecision medicine's next frontier: unlocking the power of biospecimens
MoSupernus acquires struggling Sage for $561M, taking a flier on postpartum depression drug Zurzuvae
MoEli Lilly adds high-dose Zepbound options to lineup of cheaper vials available on self-pay website
MoSarepta reports 2nd death after DMD gene therapy Elevidys, stops dosing in half of patients
MoAstraZeneca touts early Ultomiris survival data in children living with rare post-transplant complication
MoFDA's 'heavy workload' blamed for delays to KalVista's angioedema drug approval decision
MoBiogen leads Cannes Lions Pharma shortlist, with BMS, Novartis cracking Health & Wellness category
FrSens. Sanders, King propose legislation to ban direct-to-consumer ads for prescription drugs
FrMerck's Keytruda wins breakthrough head and neck cancer nod around surgery, but with a limitation
FrFierce Pharma Asia-Pfizer CEO talks bispecific deal; Otsuka's kidney disease win; Novartis-MSN Entresto feud